Raymond J. Spencer
Fondateur chez MGB Biopharma Ltd.
Postes actifs de Raymond J. Spencer
Sociétés | Poste | Début | Fin |
---|---|---|---|
MGB Biopharma Ltd.
MGB Biopharma Ltd. BiotechnologyHealth Technology MGB Biopharma Ltd. develops anti-infective medicines. Its lead candidate, MGB-BP-3, is an antibacterial which is active against important multi-resistant and susceptible Gram-positive pathogens. The firm develops an oral formulation of MGB-BP-3 for the treatment of clostridium difficile associated disease. The company was founded by Miroslav Ravic, Gavin David Clark and Raymond Spencer in 2010 and is headquartered in Glasgow, the United Kingdom. | Directeur/Membre du Conseil | - | - |
Directeur Financier/CFO | 19/04/2010 | - | |
Fondateur | 19/04/2010 | - | |
Powersolar Renewables Ltd.
Powersolar Renewables Ltd. Alternative Power GenerationUtilities Powersolar Renewables Ltd. is a holding British company that operates through its subsidiaries to generate solar power. | Directeur/Membre du Conseil | - | - |
Historique de carrière de Raymond J. Spencer
Anciens postes connus de Raymond J. Spencer
Sociétés | Poste | Début | Fin |
---|---|---|---|
Summit Therapeutics Ltd.
Summit Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Summit Therapeutics Ltd. operates as a holding company, which engages in the discovery, development, and commercialization of antibiotic medicines. The company seeks to expand its product candidate portfolio through the development of new mechanism and precision antibiotics. Summit Therapeutics was founded by Stephen Graham Davies and Kay Dame Davies in January 2003 and is headquartered in Abingdon, the United Kingdom. | Directeur Financier/CFO | 28/08/2009 | 23/06/2014 |
Secrétaire Général | 16/11/2010 | - | |
Sarossa Capital Ltd.
Sarossa Capital Ltd. Financial ConglomeratesFinance Sarossa Capital Ltd. is an investment holding and management company. Its principal activity is investing in and growth and development of businesses which present opportunities for value creations. The company currently intends to indentify investment opportunities offering the potential to deliver a favorable return to shareholders over the medium term, primarily in the form of capital gain. The company was founded in 1988 and is headquartered in London, the United Kingdom. | Directeur Financier/CFO | - | - |
Formation de Raymond J. Spencer
University of Bristol | Undergraduate Degree |
Statistiques
Internationale
Royaume-Uni | 6 |
Opérationnelle
Director of Finance/CFO | 3 |
Director/Board Member | 2 |
Corporate Secretary | 1 |
Sectorielle
Health Technology | 3 |
Finance | 2 |
Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 4 |
---|---|
Sarossa Capital Ltd.
Sarossa Capital Ltd. Financial ConglomeratesFinance Sarossa Capital Ltd. is an investment holding and management company. Its principal activity is investing in and growth and development of businesses which present opportunities for value creations. The company currently intends to indentify investment opportunities offering the potential to deliver a favorable return to shareholders over the medium term, primarily in the form of capital gain. The company was founded in 1988 and is headquartered in London, the United Kingdom. | Finance |
Summit Therapeutics Ltd.
Summit Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Summit Therapeutics Ltd. operates as a holding company, which engages in the discovery, development, and commercialization of antibiotic medicines. The company seeks to expand its product candidate portfolio through the development of new mechanism and precision antibiotics. Summit Therapeutics was founded by Stephen Graham Davies and Kay Dame Davies in January 2003 and is headquartered in Abingdon, the United Kingdom. | Health Technology |
MGB Biopharma Ltd.
MGB Biopharma Ltd. BiotechnologyHealth Technology MGB Biopharma Ltd. develops anti-infective medicines. Its lead candidate, MGB-BP-3, is an antibacterial which is active against important multi-resistant and susceptible Gram-positive pathogens. The firm develops an oral formulation of MGB-BP-3 for the treatment of clostridium difficile associated disease. The company was founded by Miroslav Ravic, Gavin David Clark and Raymond Spencer in 2010 and is headquartered in Glasgow, the United Kingdom. | Health Technology |
Powersolar Renewables Ltd.
Powersolar Renewables Ltd. Alternative Power GenerationUtilities Powersolar Renewables Ltd. is a holding British company that operates through its subsidiaries to generate solar power. | Utilities |
- Bourse
- Insiders
- Raymond J. Spencer
- Expérience